Clik here to view.
Stop Dieting! Start Lipo-ing!
SEOUL, South Korea Dieting is an unsolvable problem to a lot of people. Many has abdominal obesity because of sitting down all the time from work, irregular hours, company outing, and lack of...
View ArticleClik here to view.
Takeda to Highlight Ixazomib Clinical Development Program at Upcoming...
ROME Takeda Pharmaceutical Company Limited (TSE: 4502) today announced that it will highlight the ixazomib clinical development program during multiple poster sessions at the upcoming 15th...
View ArticleClik here to view.
GE Healthcare Announces $300 Million Commitment to Support Emerging Market...
NEW YORK GE Healthcare, the $18 billion healthcare technology division of GE (NYSE: GE), today announced the creation of a new business unit, Sustainable Healthcare Solutions (SHS), that will...
View ArticleClik here to view.
Alliance HealthCare Services Provides Business Update
NEWPORT BEACH, Calif. Alliance HealthCare Services, Inc. (NASDAQ:AIQ) (the “Company” or “Alliance”), a leading national provider of outsourced diagnostic imaging through its Alliance HealthCare...
View ArticleClik here to view.
EOS imaging Announces Second Installation in Hong Kong
PARIS EOS imaging (Euronext, FR0011191766 – EOSI), the pioneer in 2D/3D orthopedic medical imaging, announced today that The Duchess of Kent Children’s Hospital has become the second hospital in...
View ArticleClik here to view.
Clik here to view.
武田薬品が来る国際骨髄腫ワークショップでイキサゾミブの臨床開発プログラムについて報告
ローマ （ビジネスワイヤ）– 武田薬品工業株式会社（TSE: 4502）は本日、2015年9月23～26日にイタリアのローマで開催される第15回国際骨髄腫ワークショップ（IMW 2015）の複数のポスターセッションで、イキサゾミブの臨床開発プログラムについて報告すると発表しました。 武田薬品Oncology Therapeutic Area...
View ArticleClik here to view.
武田在即将召开的国际骨髓瘤研讨会上介绍Ixazomib临床开发项目
罗马 (美国商业资讯)–武田药品工业株式会社(TSE: 4502)今天宣布，将在第15届国际骨髓瘤研讨会(IMW 2015)的多个壁报分会场上介绍ixazomib 临床开发项目，此次研讨会将于2015年9月23至26日在意大利罗马召开。 武田肿瘤治疗领域部门副总裁Dixie-Lee Esseltine, MD,...
View ArticleClik here to view.
Presbia to Participate in the 2015 Australasian Society of Cataract and...
DUBLIN Presbia PLC (NASDAQ: LENS), an ophthalmic device company and leader in near-vision restoration will be attending the 19th Annual Australasian Society of Cataract and Refractive Surgeons...
View ArticleClik here to view.
THERAVECTYS Appoints Dr. Jean-Pierre Bizzari to Board of Directors
PARIS THERAVECTYS, a Paris-based, fully-integrated discovery & clinical development company specialized in lentiviral vector-based therapeutic vaccines and T-cell therapies, is proud to announce...
View ArticleClik here to view.
Clik here to view.
Cynvenio Biosystems and ATGen Announce Strategic Partnership to Bring NK Vue...
LOS ANGELES & SEOUL, South Korea Cynvenio Biosystems, Inc., a diagnostics company dedicated to enabling the new era of individualized medicine for all cancer patients, and ATGen Global, a...
View ArticleClik here to view.
Medacta Highlights Importance of Surgeon Education for the Anterior Approach...
LUGANO, Switzerland & CHICAGO This week, Medacta, a privately held, family-owned global leader in the design of innovative joint replacement and spine surgery products, celebrates a significant...
View ArticleClik here to view.
Japan’s Zilver® PTX® Two-Year Results Support Global Evidence for...
BLOOMINGTON, Ind. Dr. Kimihiko Kichikawa, Department of Radiology at Nara Medical University in Japan, reported two-year results of the Zilver® PTX® post-market surveillance (PMS) study on September...
View ArticleClik here to view.
dorsaVi Signs Three Year Sales Agreement for ViMove with Leading UK...
MELBOURNE, Australia Medical device company dorsaVi Ltd (ASX: DVL) today announced it has signed a multimillion dollar deal with leading UK physiotherapy network YourPhysioPlan to market and sell...
View ArticleClik here to view.
50+ Forensic DNA Experts to Present at the 2015 International Symposium on...
MADISON, Wis. Learn from forensic luminaries, who will share their experiences solving crimes, deciphering historical mysteries and advancing the fields of forensics and DNA analysis, at the...
View ArticleClik here to view.
Frontage Doubles Bioanalytical Lab Capacity in USA Due to Increased Demand...
EXTON, Pa. Frontage, a full service contract research organization (CRO) located in the USA and China, is pleased to announce the expansion of its bioanalytical laboratories to meet increased demand...
View ArticleClik here to view.
Bard Agrees to Acquire Full Ownership of its Joint Venture in Japan
MURRAY HILL, N.J. C. R. Bard, Inc. (NYSE:BCR) announced today that it has entered into a definitive agreement to acquire Kobayashi Pharmaceutical Co., Ltd.’s (Kobayashi) 50% ownership share in...
View ArticleClik here to view.
Transgenomic Signs Binding Term Sheet to Divest Genetic Assays & Platforms...
OMAHA, Neb. Transgenomic, Inc. (NASDAQ: TBIO) today announced that it has entered into a definitive and binding term sheet to divest its Genetic Assays & Platforms (GAP) Business Unit to ADSTEC...
View ArticleClik here to view.
Amoy Diagnostics and Illumina Enter Strategic Collaboration for...
XIAMEN, China & SAN DIEGO Amoy Diagnostics Co. Ltd. (ADx) and Illumina, Inc. (NASDAQ: ILMN) today announced a strategic collaboration to accelerate the adoption of precision medicine and...
View Article